1. Horikawa, Y, Iwasaki, N, Hara, M, et al. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet. 1997;17(4):384-385.
Google Scholar | Crossref | Medline | ISI2. Nkonge, KM, Nkonge, DK, Nkonge, TN. The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY). Clin Diabetes Endocrinol. 2020;6:20. doi:10.1186/s40842-020-00112-5.
Google Scholar | Crossref | Medline3. Juszczak, A, Owen, KR. Identifying subtypes of monogenic diabetes. Diabetes Manage. 2014;4:13.
Google Scholar | Crossref4. Roehlen, N, Hilger, H, Stock, F, et al. 17q12 deletion syndrome as a rare cause for diabetes mellitus type MODY5. J Clin Endocrinol Metab. 2018;103(10):3601-3610.
Google Scholar | Crossref | Medline5. Ferrè, S, Igarashi, P. New insights into the role of HNF-1B in kidney (patho)physiology. Pediatr Nephrol. 2019;34(8):1325-1335.
Google Scholar | Crossref | Medline6. Clissold, RL, Hamilton, AJ, Hattersley, AT, Ellard, S, Bingham, C. HNF1B-associated renal and extra-renal disease: an expanding clinical spectrum. Nat Rev Nephrol. 2015;11(2):102-112.
Google Scholar | Crossref | Medline7. Laffargue, F, Bourthoumieu, S, Llanas, B. Towards a new point of view on the phenotype of patients with a 17q12 microdeletion syndrome. Arch Dis Child. 2015;100(3):259-264.
Google Scholar | Crossref | Medline8. Mitchel, MW, Moreno-De-Luca, D, Myers, SM, et al. 17q12 recurrent deletion syndrome. In: Adam, MP, Ardinger, HH, Pagon, RA, et al, eds. GeneReviews® [Internet]. Seattle: University of Washington, Seattle; 1993-2021. https://www.ncbi.nlm.nih.gov/books/NBK401562/. Published October 15, 2020. Accessed December 9, 2021.
Google Scholar9. Dubois-Laforgue, D, Cornu, E, Saint-Martin, C, et al. Diabetes, associated clinical spectrum, long-term prognosis, and genotype/phenotype correlations in 201 adult patients with hepatocyte nuclear factor 1B (HNF1B) molecular defects. Diabetes Care. 2017;40:1436-1443.
Google Scholar | Crossref | Medline10. Faguer, S, Chassaing, N, Bandin, F, et al. The HNF1B score is a simple tool to select patients for HNF1B gene analysis. Kidney Int. 2014;86(5):1007-1015.
Google Scholar | Crossref | Medline11. Ang, SF, Lim, SC, Tan, CSH, et al. A preliminary study to evaluate the strategy of combining clinical criteria and next generation sequencing (NGS) for the identification of monogenic diabetes among multi-ethnic Asians. Diabetes Res Clin Pract. 2016;119:13-22.
Google Scholar | Crossref | Medline12. Ang, SF, Tan, CSH, Chan, LWT, et al. Clinical experience from a regional monogenic diabetes referral centre in Singapore. Diabetes Res Clin Pract. 2020;168:108390.
Google Scholar | Crossref | Medline13. Shields, BM, McDonald, TJ, Ellard, S, Campbell, MJ, Hyde, C, Hattersley, AT. The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia. 2012;55(5):1265-1272.
Google Scholar | Crossref | Medline14. Low, SKM, Lim, SC, Yeoh, LY, et al. Effect of long-term glycemic variability on estimated glomerular filtration rate decline among patients with type 2 diabetes mellitus: insights from the diabetic nephropathy cohort in Singapore. J Diabetes. 2017;9(10):908-919.
Google Scholar | Crossref | Medline15. Udler, MS, McCarthy, MI, Florez, JC, Mahajan, A. Genetic risk scores for diabetes diagnosis and precision medicine. Endocrine Reviews. 2019;40:1500-1520.
Google Scholar | Crossref | Medline16. Adler, AI, Stevens, RJ, Manley, SE, et al. UKPDS GROUP . Development and progression of nephropathy in Type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63:225-232.
Google Scholar | Crossref | Medline | ISI17. Low, SKM, Sum, CF, Yeoh, LY, et al. Prevalence of chronic kidney disease in adults with type 2 diabetes mellitus. Ann Acad Med Singap. 2015;44(5):164-171.
Google Scholar | Medline18. Bedont, JL, LeGates, TA, Slat, EA, et al. Lhx1 controls terminal differentiation and circadian function of the suprachiasmatic nucleus. Cell Rep. 2014;7(3):609-622.
Google Scholar | Crossref | Medline19. Zhao, Y, Kwan, KM, Mailloux, CM, et al. LIM-homeodomain proteins Lhx1 and Lhx5, and their cofactor Ldb1, control Purkinje cell differentiation in the developing cerebellum. Proc Natl Acad Sci USA. 2007;104(32):13182-13186.
Google Scholar | Crossref | Medline20. Girirajan, S, Dennis, MY, Baker, C, et al. Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder. Am J Hum Genet. 2013;92(2):221-237.
Google Scholar | Crossref | Medline21. Clissold, RL, Ashfield, B, Burrage, J, et al. Genome-wide methylomic analysis in individuals with HNF1B intragenic mutation and 17q12 microdeletion. Clin Epigenet. 2018;10:97.
Google Scholar | Crossref | Medline22. Verhave, J, Bech, AP, Wetzels, JFM, Nijenhuis, T. Hepatocyte nuclear factor 1B-associated kidney disease: more than renal cysts and diabetes. J Am Soc Nephrol. 2016;27:345-353.
Google Scholar | Crossref | Medline23. Groopman, EE, Povysil, G, Goldstein, DB, Gharavi, AG. Rare genetic causes of complex kidney and urological diseases. Nat Rev Nephrol. 2020;16(11):641-656.
Google Scholar | Crossref | Medline24. Shao, A, Chan, SC, Igarashi, P. Role of transcription factor hepatocyte nuclear factor-1B in polycystic kidney disease. Cell Signal. 2020;71:109568. doi:10.1016/j.cellsig.2020.109568.
Google Scholar | Crossref | Medline25. Torres, VE, Chapman, AB, Devuyst, O, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367(25):2407-2418.
Google Scholar | Crossref | Medline | ISI26. Gansevoort, RT, van Gastel, MDA, Chapman, AB, et al. Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease. Kidney Int. 2019;96(1):159-169.
Google Scholar | Crossref | Medline27. Tuttle, KR, Brosius, FC, Cavender, MA, et al. SGLT2 Inhibition for CKD and cardiovascular disease in type 2 diabetes: report of a scientific workshop sponsored by the National Kidney Foundation. Am J Kidney Dis. 2020;77(1):94-109. doi:10.1053/j.ajkd.2020.08.003.
Google Scholar | Crossref | Medline